Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Apr 7, 2009; 15(13): 1650-1652
Published online Apr 7, 2009. doi: 10.3748/wjg.15.1650
Published online Apr 7, 2009. doi: 10.3748/wjg.15.1650
Figure 1 Patient clinical course.
ALT: Alanine aminotransferase; PT: Prothrombin activity; T. Bil: Total bilirubin; HBV DNA: Hepatitis B virus DNA. At 6 wk, his serum transaminase level was normalized. At 12 wk, his serum HBV-DNA level became 3.3 LGE/mL and prednisolone was stopped.
Figure 2 Patient clinical course.
ALT: Alanine aminotransferase; PT: Prothrombin activity; T. Bil: Total bilirubin; HBV DNA: Hepatitis B virus DNA. At 8 wk, her serum transaminase level was normalized. At 15 wk, her serum HBV-DNA level became undetectable and the prednisolone was stopped.
- Citation: Matsumoto K, Miyake Y, Miyatake H, Takahara M, Imada T, Yagi S, Toyokawa T, Nakatsu M, Ando M, Hirohata M. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B. World J Gastroenterol 2009; 15(13): 1650-1652
- URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1650.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.1650